173 related articles for article (PubMed ID: 35935409)
1. Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR.
Stürup AE; Hjorthøj C; Albert N; Dolmer S; Birk M; Ebdrup BH; Eplov LF; Jensen H; Vernal DL; Speyer H; Mors O; Nordentoft M
Front Psychiatry; 2022; 13():910703. PubMed ID: 35935409
[TBL] [Abstract][Full Text] [Related]
2. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
3. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
5. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.
Kishi T; Ikuta T; Matsui Y; Inada K; Matsuda Y; Mishima K; Iwata N
Psychol Med; 2019 Apr; 49(5):772-779. PubMed ID: 29909790
[TBL] [Abstract][Full Text] [Related]
6. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
[TBL] [Abstract][Full Text] [Related]
8. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
Andrade C
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
12. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
Üçok A; Kara İA
Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
[TBL] [Abstract][Full Text] [Related]
13. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.
Asian Network of Early Psychosis Writing Group
Int J Neuropsychopharmacol; 2022 Sep; 25(9):737-758. PubMed ID: 35451023
[TBL] [Abstract][Full Text] [Related]
15. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: results from an aborted randomised trial.
Boonstra G; Burger H; Grobbee DE; Kahn RS
Int J Psychiatry Clin Pract; 2011 Jun; 15(2):128-34. PubMed ID: 22121861
[TBL] [Abstract][Full Text] [Related]
17. Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
Landolt K; Rössler W; Ajdacic-Gross V; Derks EM; Libiger J; Kahn RS; Fleischhacker WW;
Schizophr Res; 2016 Apr; 172(1-3):145-51. PubMed ID: 26922655
[TBL] [Abstract][Full Text] [Related]
18. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.
Emsley R; Chiliza B; Asmal L; du Plessis S; Phahladira L; van Niekerk E; van Rensburg SJ; Harvey BH
Schizophr Res; 2014 Sep; 158(1-3):230-5. PubMed ID: 24996507
[TBL] [Abstract][Full Text] [Related]
20. Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis.
Thompson A; Singh S; Birchwood M
Early Interv Psychiatry; 2016 Aug; 10(4):355-61. PubMed ID: 25962446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
